Cardiac Science To Challenge Philips As Sole Biphasic AED Player In Japan
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Science anticipates receiving approval from the Japanese Ministry of Health, Labour & Welfare for a biphasic automated external defibrillator by the end of Q2, the firm says
You may also be interested in...
Cardiac Science Aims To Recoup Japan Losses With Biphasic AEDs
Cardiac Science expects to regain share of the Japanese automatic external defibrillator market with the launch of its biphasic AEDs in Japan, according to CEO Raymond Cohen
Cardiac Science Aims To Recoup Japan Losses With Biphasic AEDs
Cardiac Science expects to regain share of the Japanese automatic external defibrillator market with the launch of its biphasic AEDs in Japan, according to CEO Raymond Cohen
Zoll discusses GE/Cardiac Science deal
While "GE has been in the defibrillation business a few times," Zoll Medical CEO Richard Packer says the firm "never really goes at it with full force" as "they see [defibrillation] as complimentary" to their business, rather than "necessary." The exec's comments, which came June 15 at a Thomas Weisel conference, responded to a question about whether Zoll expected to feel any impact from Cardiac Science's recently inked North American distribution agreement with GE Healthcare for the PowerHeart ECD defibrillator (1"The Gray Sheet" May 9, 2005, p. 25). Zoll manufacturers the LifeVest defibrillator...